The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

The inflammatory bowel disease treatment market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of almost 5%, as per The Business Research Company’s market report!

Read More On The Inflammatory Bowel Disease Treatment Market Report 2022 – https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

The Inflammatory Bowel Disease Treatment Market Size In 2022 And Forecast

The global inflammatory bowel disease treatment market is expected to grow from $19.52 billion in 2021 to $20.48 billion in 2022 at a compound annual growth rate (CAGR) of 4.93%. The global inflammatory bowel disease market size is expected to grow to $24.84 billion in 2026 at a compound annual growth rate (CAGR) of 4.94%.

The inflammatory bowel disease treatment market consists of sales of inflammatory bowel disease therapeutics and drugs by entities (organizations, partnerships, and sole proprietors) that are used to provide medical treatment for inflammatory bowel diseases.

Request for A Sample Of The Global Inflammatory Bowel Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

Rise In Prevalence Of Crohn’s Disease And Ulcerative Colitis Is Driving The Growth Of The Inflammatory Bowel Disease Treatment Market

For instance, according to a 2019 report by the Crohn’s & Colitis Foundation (CCFA), around 1.6 million Americans currently (2019) suffer from inflammatory bowel disease (Crohn’s disease or ulcerative colitis), showing an increase of around 200,000 since the last time it reported this figure in 2011. Around 70,000 new cases of IBD are diagnosed every year in the USA. Hence, the rising prevalence of Crohn’s disease and ulcerative colitis is expected to drive the inflammatory bowel disease treatment market.

Competitive Landscape And The Regional Analysis Of The Inflammatory Bowel Disease Treatment Market

Major players in the inflammatory bowel disease treatment market are AbbVie Inc, Biogen, Johnson & Johnson, Amgen Inc, UCB SA, Novartis AG, Takeda Pharmaceutical Company Limited, Merck & Co, Pfizer Inc, Abbott Laboratories, Janssen Biotech Inc, Eli Lilly, Allergan plc, Alkem Laboratories Limited, and Bausch Health Companies Inc.

Additionally, as per TBRC’s research – North America was the largest region in the inflammatory bowel disease treatment market in 2021 holding the largest market share and Asia-Pacific is expected to be the fastest-growing region in the forecast period.

The Inflammatory Bowel Disease Treatment Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the inflammatory bowel disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the inflammatory bowel disease treatment market.

Technological Advancement – A Key Trend In The Inflammatory Bowel Disease Treatment Market

The key players in the inflammatory bowel disease treatment market are focusing on using technology such as artificial intelligence (AI) for the drug discovery process as well as offering advanced but new inflammatory bowel disease treatments. To attain their technological innovations, key players and technology companies are partnering to leverage each other’s competencies and technology to develop new treatments and strengthen their key position in the market.

Inflammatory Bowel Disease Treatment Market Segmentation By The Business Research Company

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Others

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Here Are Some Reports Related To The Inflammatory Bowel Disease Treatment Market –

Gastrointestinal Drugs Global Market Report 2022

Gastrointestinal Devices Global Market Report 2022

Digestive Enzymes Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: